The potential of breast cancer screening in Europe.

International Journal of Cancer. Journal International Du Cancer
Nadine ZielonkeEU-TOPIA collaborators

Abstract

Currently, all European countries offer some form of breast cancer screening. Nevertheless, disparities exist in the status of implementation, attendance and the extent of opportunistic screening. As a result, breast cancer screening has not yet reached its full potential. We examined how many breast cancer deaths could be prevented if all European countries would biennially screen all women aged 50 to 69 for breast cancer. We calculated the number of breast cancer deaths already prevented due to screening as well as the number of breast cancer deaths which could be additionally prevented if the total examination coverage (organised plus opportunistic) would reach 100%. The calculations are based on total examination coverage in women aged 50 to 69, the annual number of breast cancer deaths for women aged 50 to 74 and the maximal possible mortality reduction from breast cancer, assuming similar effectiveness of organised and opportunistic screening. The total examination coverage ranged from 49% (East), 62% (West), 64% (North) to 69% (South). Yearly 21 680 breast cancer deaths have already been prevented due to mammography screening. If all countries would reach 100% examination coverage, 12 434 additional breast cancer deaths ...Continue Reading

References

Nov 21, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N PerryL von Karsa
Jul 31, 2008·Journal of the National Cancer Institute·Solveig HofvindBerta M Geller
Jul 31, 2008·British Journal of Cancer·D PulitiUNKNOWN IMPACT Working Group
Nov 29, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Rianne de GelderHarry J de Koning
Mar 14, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-L BulliardF Levi
Aug 20, 2011·Journal of Medical Screening·Josep A EspinasJosep M Borras
Jan 11, 2012·Breast Cancer Research : BCR·Donella PulitiEugenio Paci
Apr 26, 2012·International Journal of Cancer. Journal International Du Cancer·Anne Helene OlsenEiliv Lund
Nov 8, 2012·Journal of Medical Screening·Mireille BroedersUNKNOWN EUROSCREEN Working Group
Nov 8, 2012·Journal of Medical Screening·S M MossUNKNOWN Euroscreen Working Group
Dec 14, 2012·BMC Medicine·Philippe Autier, Mathieu Boniol
Apr 2, 2013·Lancet·Johan P MackenbachMartin McKee
May 15, 2013·BMC Public Health·Laura CamilloniUNKNOWN Methods to increase participation Working Group
Jun 8, 2013·British Journal of Cancer·M G MarmotM Wilcox
Apr 10, 2014·The Breast : Official Journal of the European Society of Mastology·Ellen PaapMireille J M Broeders
Jun 22, 2014·BMJ : British Medical Journal·Harald Weedon-FekjærLars J Vatten
Jun 4, 2015·The New England Journal of Medicine·Béatrice Lauby-SecretanUNKNOWN International Agency for Research on Cancer Handbook Working Group
Dec 10, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nathalie J MassatStephen W Duffy
Mar 25, 2016·British Journal of Cancer·Sirpa HeinävaaraAhti Anttila
Sep 25, 2017·International Journal of Cancer. Journal International Du Cancer·Partha BasuRengaswamy Sankaranarayanan
Aug 14, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Jan 15, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nadine ZielonkeUNKNOWN EU-TOPIA consortium

❮ Previous
Next ❯

Software Mentioned

TOwards

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)
M J M Broeders, A L M Verbeek
American Family Physician
Maria Tria Tirona
JAMA : the Journal of the American Medical Association
Kevin C OeffingerAmerican Cancer Society
Journal of Cancer Research and Clinical Oncology
Line Flytkjær VirgilsenPeter Vedsted
© 2021 Meta ULC. All rights reserved